by New research suggests that an over-the-counter supplement could potentially enhance walking ability for individuals diagnosed with peripheral artery disease (PAD). The study, published in the American Journal of Clinical Nutrition, adds to the growing body of evidence supporting the role of nutritional interventions in managing symptoms and improving quality of life for PAD patients.
According to the study, patients who took a daily dose of an omega-3 fatty acid supplement, specifically EPA and DHA, experienced significant improvements in their six-minute walk test (6MWT) distances compared to those who did not take the supplement. The 6MWT is a commonly used assessment tool to evaluate faster walking capacity and functional limitations in patients with PAD.
The randomized, double-blind, placebo-controlled trial involved 126 participants with PAD, who were randomly assigned to receive either a daily omega-3 supplement or a placebo for six months. The results showed that those who took the supplement experienced an average increase of 33.6 meters in their 6MWT distances, while the placebo group only saw an improvement of 11.4 meters.
These findings add to the existing evidence supporting the benefits of omega-3 fatty acids for individuals with PAD. Previous studies have shown that these essential nutrients can help reduce inflammation, improve blood flow, and reduce the risk of cardiovascular events in patients with PAD.
The researchers emphasized that while the study provides promising results, more research is needed to fully understand the potential benefits and optimal dosages of omega-3 supplements for PAD patients. They also encouraged individuals with PAD to discuss the use of supplements with their healthcare providers before making any decisions.
the latest study offers hope for individuals with peripheral artery disease, as an over-the-counter supplement may help improve their walking ability and overall quality of life. However, further research is required to fully understand the potential benefits and risks associated with omega-3 supplementation for PAD patients.
For more information on peripheral artery disease and available treatment options, please consult your healthcare provider or visit our website for the latest news and resources.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
